Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential
Sign Up to like & getrecommendations! Published in 2023 at "Expert Review of Anti-infective Therapy"
DOI: 10.1080/14787210.2023.2170350
Abstract: ABSTRACT Introduction Tecovirimat oral capsule formulation is approved in the US and Canada for treatment of smallpox and in the United Kingdom (UK) and European Union (EU) for treatment of multiple human orthopoxvirus diseases, including… read more here.
Keywords: mpox; formulation; smallpox; development ... See more keywords
A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14091870
Abstract: Monkeypox disease (MPX) is currently considered a global threat after COVID-19. European Medicines Agency (EMA) approved Tecovirimat in capsule dosage form (200 mg) as the first treatment for MPX in January 2022. This article highlights… read more here.
Keywords: drug; patent literature; development patent; tecovirimat ... See more keywords
MONKEYPOX DISEASE TREATMENT BY TECOVIRIMAT ADSORBED ONTO SINGLE-WALLED CARBON NANOTUBE THROUGH DRUG DELIVERY METHOD
Sign Up to like & getrecommendations! Published in 2023 at "Journal of the Chilean Chemical Society"
DOI: 10.4067/s0717-97072023000105796
Abstract: In this work, it has been investigated the Monkeypox disease which occurs in both humans and animals by infection with a double-stranded DNA virus having the symptoms consisting of fever, fatigue, headache, and muscle pains… read more here.
Keywords: single walled; drug delivery; monkeypox disease; drug ... See more keywords
Tecovirimat Treatment of People With HIV During the 2022 Mpox Outbreak
Sign Up to like & getrecommendations! Published in 2023 at "Annals of Internal Medicine"
DOI: 10.7326/m22-3132
Abstract: BACKGROUND The recent mpox outbreak has disproportionately affected people with HIV (PWH) and resulted in the first widespread use of the novel antiviral tecovirimat. Whether treatment outcomes differ between PWH and those without HIV is… read more here.
Keywords: treated tecovirimat; treatment outcomes; treatment; mpox outbreak ... See more keywords